T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex: Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31

Journal of Immunology

Volumn 156, Issue 10, 1996, Pages 3815-3820

  Wu, Shenhong ^a   Gorski, Jack ^a   Eckels, David D ^a   Newton Nash, Debra K ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CELL CLONE; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; AMINO ACIDS; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HLA-DR ANTIGENS; HUMANS; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; SODIUM DODECYL SULFATE; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 0029963942     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
2. Brown, J. H., T. Jardetzky, M. A. Saper, B. Sararaoui, P. J. Bjorkman, and D. C. Wiley. 1988 A hypothetical model of the foreign antigen binding site of class n histocompatibility molecules. Nature 332:845.
3. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993 Three-dimensional structure of the human class E histocompatibility antigen HLA-DR1. Nature 364:33.
4. Stern, L. J., J. H Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J L Strominger, and D C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 completed with an influenza virus peptide. Nature 368:215.
5. Chavin, K. D., L. Qin, J. E. Woodward, J. Lin, and J S. Bromberg. 1994. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. Transplantation 57:736.
6. Buus, S., A. Sette, S. M. Colon, C. Miles, and H. M. Grey. 1987. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235:1353.
7. Garrett, T. P , M. A Saper, P. J. Bjorkman, J. L. Strominger, and D. C. Wiley. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692.
8. Falk, K., O. Rotzschke, S. Stevanoic, G Jung, and H. Rammensee 1991 Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
9. b. Science 257:919.
10. Matsumura, M., D. H Fremont, P. A. Peterson, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
11. Guo, H-C., D. R. Madden, M. L. Silver, T S. Jardetzky, J. C Gorga, J. L. Strominger, and D. C. Wiley. 1993. Comparison of the P2 specificity pocket in three human histocompatibility antigens HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc. Natl. Acad. Sci. USA 90:8053.
12. Rothbard, J. B., R. Busch, K. Rowland, V. Bal, C. Fenton, W. R. Taylor, and J. R. Lamb. 1989. Structural analysis of a peptide-HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor Int Immunol. 1:479.
13. Jardetzky, T. S., J. C. Gorga, R. Busch, J. Rothbard, I. L. Strominger, and D. C. Wiley. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding EMBO J. 9:1797.
14. Newton-Nash, D. K., and D. D. Eckels 1993. Differential effect of polymorphism at HLA-DR1 β-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J. Immunol. 150:1813.
15. O'Sullivan, D , T Arrhenius, J. Sidney, M. F Del Guercio, M. Albertson, M Wall, C. Oseroff, S Southwood, S. M. Colon, F C. Gaeta, and A. Sette 1991. On the interaction of promiscuous antigenic peptides with different DR alleles: identification of common structural motifs. J. Immunol. 147:2663.
16. Hammer, J., B Takacs, and F. Sinigaglia. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries J. Exp. Med. 176:1007.
17. Rothbard, J B., R. I. Lechler, K. Howland, V. Bal, D. D. Eckels, R. Sekaly, E. O. Long, W. R. Taylor, and J. R Lamb. 1988. Structural model of HLA-DR1 restricted T cell antigen recognition Cell 52:515.
18. Hill, C M , J. D. Hayball, A A Allison, and J. B. Rothbard. 1991. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147:189.
19. Springer, T. A., J F. Kaufman, L. A Siddoway, D. L. Mann, and J. L. Strominger. 1977. Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association J. Biol Chem. 252:6201.
20. Cresswell. P. 1977. Human B cell alloantigens: separation from other membrane molecules by affinity chromatography. Eur. J. Immunol. 7:636.
21. Gorga, J. C , V. Horejsi, D. R. Johnson, R. Raghupathy, and J. L. Strominger. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line J. Biol. Chem. 262:16087.
22. Davis, J. E., R R. Rich, M. Van, H. V. Le, M. S. Pollack, and R. G Cook 1987. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency. J. Clin Invest 80: 998.
23. Germain, R. N., and L R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
24. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71.
25. Stern, L. J., and D C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 68:465.
26. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
27. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363.725.
28. Lanzavecchia, A., P. A. Reid, and C Watts. 1992. Irreversible association of peptides with class n MHC molecules in living cells. Nature 357:249.
29. Nelson, C. A., S. J. Petzold, and E. R Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90:1227.
30. Goyert, S. M., and J. Silver. 1983 Further characterization of HLA-DS molecules, implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. Proc Natl. Acad. Sci USA 80:5719.
31. Madrigal, J. A., H. Ikeda, S. G. Marsh, J. M. Heyes, L. J. Kennedy, J Trowsdale, and I. G. Bodmer. 1989 Epitope mapping of an HLA-DR-speciflc monoclonal antibody produced by using human-mouse transfectam cells. J. Immunol 143: 4084.
32. Shackelford, D. A., J. F. Kaufman, A. J. Konnan, and J L. Strominger 1982 HLA-DR antigens: structure, separation of subpopulations, gene cloning and function. Immunol. Rev. 66-133.
33. Guy, K , V. Van Heyningen, B. B. Cohen, D. L. Deane, and C. M. Steele. 1995. Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur. J. Immunol. 12:942.
34. Fuggle, S. V., C. Carter, F. Watts, J Kirkley, and P. J Morns. 1987. Monoclonal antibody definition of multiple polymorphic epitopes on human leukocyte antigen-DRw52. Hum. Immunol. 20:249.
35. 1 chains determine polymorphic epitopes recognized by monoclonal antibodies. J. Immunol. 143:2248
36. Dommair, K, and H. M. McConnell. 1990. Refolding and reassembly of separate a and β chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity. Proc. Natl. Acad. Sci. USA 87:4134.
37. Harding, C V , and E. R. Unanue. 1990 Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346: 374.
38. Demotz, S., H M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249:1028
39. Sadegh-Nasseri, S., L. J. Stem, D C. Wiley, and R. N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding Nature 370:647.
40. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
41. Hedley, M. L., R. G. Urban, and J. L. Strominger. 1994. Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system. Proc. Natl. Acad. Sci USA 91:10479
42. Bijlmakers, M.-J. P E., P. Benaroch, and H. L. Ploegh. 1996. Assembly of HLA DRi molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain EMBO J. 13:2699.
43. Wu, S., and J. Gorski. 1996 The MHC class II-associated invariant chain-derived peptide CLIP binds to the peptide-binding groove of class n molecules Mol. Immunol. In press
44. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152-3946.
45. Chicz, R. M , R G Urban, W S. Lane, J. C. Gorga, L. I. Stem, D. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.